BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22776000)

  • 21. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus.
    Zhang WY; Liu W; Zhou YM; Shen XM; Wang YF; Tang GY
    Oral Dis; 2012 Apr; 18(3):265-70. PubMed ID: 22077423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous anaplastic large cell lymphomas: a report of 9 cases from Thailand.
    Eimpunth S; Sittinamsuwan P; Pattanaprichakul P; Silpa-archa N; Sethabutra P; Chularojanamontri L; Hanamornroongruang S; Mahaisavariya P
    J Med Assoc Thai; 2012 Mar; 95(3):437-43. PubMed ID: 22550845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.
    Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F
    J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides.
    Kang SK; Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
    Clin Exp Dermatol; 2002 May; 27(3):212-5. PubMed ID: 12072011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.
    Gao C; McCormack CJ; van der Weyden C; Twigger R; Buelens O; Lade S; Khoo C; Campbell BA; Goh M; McKelvie P; Prince HM
    J Am Acad Dermatol; 2021 Jan; 84(1):185-187. PubMed ID: 32334059
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA Signature in Early-stage Mycosis Fungoides.
    Sørensen ST; Litman T; Gluud M; Celis P; Torres-Rusillo S; Willerslev-Olsen A; Ødum N; Iversen L; Lindahl LM
    Acta Derm Venereol; 2022 Oct; 102():adv00785. PubMed ID: 35788691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
    Benner MF; Willemze R
    Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of mycosis fungoides after CD30 positive anaplastic large cell lymphoma.
    Lee MW; Chi DH; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2000 Jul; 27(7):458-61. PubMed ID: 10935344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
    Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
    PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK Expression is a Rare Finding in Mycosis Fungoides.
    Covington M; Cassarino D; Abdulla F
    Am J Dermatopathol; 2017 May; 39(5):342-343. PubMed ID: 28426485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
    Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
    Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA in mycosis fungoides and skin inflammation.
    Persson JL
    APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
    Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
    Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.